You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Bulk Pharmaceutical API Sources for HEDULIN


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for HEDULIN

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ⤷  Get Started Free P26406_ALDRICH ⤷  Get Started Free
Vitas-M Laboratory ⤷  Get Started Free STK395038 ⤷  Get Started Free
TCI (Tokyo Chemical Industry) ⤷  Get Started Free P1029 ⤷  Get Started Free
Molport ⤷  Get Started Free MolPort-001-783-429 ⤷  Get Started Free
AKos Consulting & Solutions ⤷  Get Started Free AKOS000445019 ⤷  Get Started Free
TimTec ⤷  Get Started Free ST45021959 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for HEDULIN

Last updated: July 27, 2025

Introduction

HEDULIN, known generically as Promethazine Hydrochloride, is an antihistamine primarily used to treat allergies, nausea, and motion sickness. Its widespread application in clinical settings positions it as a vital pharmaceutical product, with a consistent demand for high-quality Active Pharmaceutical Ingredients (APIs). Securing reliable API sources is critical for pharmaceutical manufacturers to ensure drug efficacy, safety, compliance, and cost-effectiveness. This article examines the global API landscape for HEDULIN, focusing on primary sourcing regions, key manufacturers, quality standards, and strategic procurement considerations.

Understanding HEDULIN and Its API

Promethazine Hydrochloride is chemically characterized by its phenothiazine structure, functioning mainly as an antihistamine with sedative properties. Its API must meet rigorous pharmacopeial standards, including specifications for purity, stability, and consistency. The manufacturing process involves complex chemical synthesis, often requiring advanced facilities and strict quality controls to adhere to Good Manufacturing Practice (GMP).

Global API Sourcing Regions for HEDULIN

1. China

China remains a dominant supplier of APIs globally, including Promethazine Hydrochloride. Its industry benefits from large-scale manufacturing capabilities, cost efficiencies, and a broad supplier base. Several Chinese pharmaceutical companies have obtained GMP certification and are capable of producing high-quality APIs that meet international standards. Notable companies include:

  • Zhejiang Hisun Pharmaceutical Co., Ltd.
  • Shanghai Desano Pharmaceutical Co., Ltd.
  • Zhejiang Guanghua Pharmaceutical Co., Ltd.

Chinese API manufacturers often offer competitive pricing, making China a preferred sourcing destination for cost-sensitive buyers. However, rigorous quality verification and qualification processes are essential due to variability in manufacturing practices across some suppliers.

2. India

India is recognized for its high-quality pharmaceutical manufacturing infrastructure and stringent regulatory environment overseen by the Central Drugs Standard Control Organization (CDSCO). Indian API producers often possess advanced synthesis capabilities and adhere to global quality standards, including EU-GMP and US-FDA compliance. Key Indian API manufacturers include:

  • Aarti Drugs Ltd.
  • IPCA Laboratories
  • Divi's Laboratories

Indian companies provide high-purity Promethazine Hydrochloride APIs tailored for export markets, with emphasis on regulatory compliance and consistent quality.

3. Europe and North America

While not mainstream API producers for bulk quantities, select European and North American manufacturers focus on high-grade APIs, primarily for specialty or regulated markets. These regions support robust quality assurance systems and supply APIs that meet strict regulatory standards, including Pharmacopoeial monographs and other pharmaceutical directives. Examples include:

  • Solara Active Pharma Sciences (India with European distribution)
  • Divi's Laboratories (India with international certifications)

Their APIs are often preferred for formulations requiring the highest regulatory scrutiny and are usually sold at premium prices, suitable for niche or highly regulated markets.

Key Manufacturers of Promethazine Hydrochloride API

Manufacturer Location Certification Notes
Zhejiang Hisun Pharmaceutical China GMP Large-scale production, broad product portfolio
Aarti Drugs Ltd. India WHO-GMP, ISO Focus on high quality, consistent supplies
IPCA Laboratories India US-FDA, EU-GMP High regulatory standards, export-oriented
Zhejiang Guanghua Pharmaceutical China GMP Competitive pricing, reliable delivery

Note: Due diligence is critical; verification of certifications, past compliance records, and site audits are recommended before engaging suppliers.

Quality Standards and Regulatory Compliance

API manufacturers supplying Promethazine Hydrochloride must comply with internationally recognized standards including:

  • GMP (Good Manufacturing Practice)
  • USP, EP, or BP monographs (as applicable)
  • Certifications from regulatory agencies such as the US-FDA or EU Authorities
  • Analytical validation for purity, residual solvents, heavy metals, and stereochemistry

Manufacturers providing APIs compliant with these standards minimize regulatory hurdles during drug approval processes and ensure product safety and efficacy.

Procurement Strategies and Considerations

1. Supplier Qualification

Establish rigorous qualification processes, including facility audits, review of compliance history, and verification of analytical testing capabilities. Selecting suppliers with robust quality assurance systems reduces risk of batch failures and regulatory non-compliance.

2. Quality Agreements

Negotiate clear quality agreements delineating specifications, testing responsibilities, and rejection criteria. Incorporate provisions for stability studies and batch traceability.

3. Cost versus Quality

Balance cost considerations with quality requirements. While Chinese suppliers may offer lower prices, Indian and European manufacturers often ensure higher compliance and consistency, reducing overall supply chain risk.

4. Lead Times and Capacity

Assess supplier capacity to meet demand forecasts, particularly in the context of global disruptions or regulatory bottlenecks. Long-term contracts or strategic partnerships can stabilize supply.

5. Regulatory and Export Considerations

Ensure suppliers are familiar with the importing country's regulations, including documentation requirements, certification, and customs procedures.

Emerging Trends in API Sourcing for HEDULIN

  • Supply Chain Diversification: To mitigate geopolitical or regional disruptions, companies increasingly diversify sources across multiple regions.
  • Quality Certification Emphasis: Regulatory agencies' tightening standards amplify the need for suppliers with proven GMP compliance and transparent quality audits.
  • Bioequivalence and Specialty Sourcing: For formulations requiring specific bioavailability profiles, sourcing high-purity APIs from European or North American suppliers may be advantageous despite higher costs.
  • Sustainable and Ethical Sourcing: Growing stakeholder interest in environmentally sustainable manufacturing practices influences procurement decisions.

Conclusion

The global APIdustry for Promethazine Hydrochloride offers multiple sourcing options, predominantly concentrated in China and India, with select high-standard suppliers in Europe and North America. A strategic approach involves rigorous supplier qualification, adherence to regulatory standards, and balancing cost with quality. By establishing reliable and compliant API supply chains, pharmaceutical companies can ensure continuous production, regulatory compliance, and ultimately, the delivery of safe and effective HEDULIN formulations.


Key Takeaways

  • Chinese and Indian manufacturers dominate the global Promethazine Hydrochloride API market, offering cost-effective options with varying quality standards.
  • European and North American sources provide high-quality APIs suitable for highly regulated markets, often at premium prices.
  • Rigorous supplier qualification, documentation, and compliance verification are critical to mitigate supply chain risks.
  • Strategic diversification and emphasis on quality standards ensure regulatory compliance and product safety.
  • Emerging trends, including sustainability and bioequivalence considerations, influence sourcing strategies.

Frequently Asked Questions

1. What are the primary regions sourcing Promethazine Hydrochloride API globally?
China and India are the main sourcing regions, with European and North American suppliers catering to high-standard, regulated markets.

2. How can a pharmaceutical company verify the quality of APIs from overseas suppliers?
Through supplier qualification processes, including audits, review of GMP certifications, regulatory compliance records, and analytical testing of sample batches.

3. What are the regulatory considerations when sourcing Promethazine Hydrochloride API?
Compliance with GMP, adherence to pharmacopeial standards (USP, EP, BP), and certification by authorities like US-FDA are essential.

4. Is cost the only factor in selecting an API supplier?
No. Quality, regulatory compliance, supply reliability, and supplier reputation are equally critical to ensure product safety and minimize regulatory risks.

5. What future trends are shaping API sourcing for HEDULIN?
Supply chain diversification, emphasis on high-quality manufacturing standards, sustainability, and bioequivalence are Influencing procurement strategies.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.